XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes (Tables)
9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

Income tax expense differed from the expected expense computed by applying the U.S. Federal income tax rate as follows:

  

         
   Nine Months Ended   Three Months Ended 
   September 30, 2022   September 30, 2022 
Federal income tax benefit at statutory rate  $(2,733,779)  $(845,722)
State income tax benefit   (719,896)   (222,707)
Permanent differences   11,920    3,157 
Change in valuation allowance   3,685,697    1,246,403 
Research and development tax credit adjustment   (131,681)   (131,681)
Other   (112,261)   (49,450)
Total income tax expense  $-   $- 
Schedule of Deferred Tax Assets and Liabilities

 

   September 30, 2022   December 31, 2021 
Deferred income tax assets:          
Current:          
Contingent liability  $71,550   $- 
Other   -    4,050 
Non-current:          
Net operating losses   2,616,726    1,201,974 
Research and development costs   1,694,249    - 
Unvested stock options   172,313    11,835 
Research and development tax credits   131,681    - 
Patents   104,726    90,480 
Other   69,010    49,606 
Gross deferred income tax assets   4,860,255    1,357,945 
Less: valuation allowance   (4,532,968)   (847,269)
Net deferred income tax asset   327,287    510,676 
           
Deferred income tax liabilities:          
Current:          
Accrual to cash   (3,843)   (105,075)
Non-current          
Property and equipment   (323,444)   (405,601)
Gross deferred income tax liabilities   (327,287)   (510,676)
           
Net deferred tax asset (liability)  $-   $-